Clarification
Jyothy Laboratories Ltd vide letter dated June 02, 2016 has informed BSE regarding Clarification on Speculative news article in certain section of media, titled: "Henkel likely to invest in Jyothy Labs".02-06-2016
Clarification
Jyothy Laboratories Ltd vide letter dated June 02, 2016 has informed BSE regarding Clarification on Speculative news article in certain section of media, titled: "Henkel likely to invest in Jyothy Labs".Intimation of Schedule of Analyst/ Institutional Conference
Jyothy Laboratories Ltd has informed BSE regarding "Intimation of Schedule of Analyst/ Institutional Conference".Henkel AG may invest in Jyothy Labs
For the record, Henkel AG had the option to pick up to 26 per cent stake in Jyothy five years after the latter acquired its Indian subsidiary in May 2011Analyst Meet Presentation
Jyothy Laboratories Ltd has submitted to BSE a copy of "Analyst Meet Presentation".Fixes Book Closure for Final Dividend & AGM
Jyothy Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 16, 2016 to July 21, 2016 (both days inclusive) for the purpose of Payment of Final Dividend & 25th Annual General Meeting (AGM) of the Company to be held on July 21, 2016.Jyothy Laboratories Q4 profit up 31.58% to Rs35.61 crore
Jyothy Laboratories' consolidated net sales rose 12.39% to `445.21 crore from `396.12 crore a year agoOutcome of Board Meeting
Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2016, inter alia, has also considered and approved a Scheme of Amalgamation under Section 391-394 of the Companies Act, 1956 for amalgamation of Jyothy Consumer Products Marketing Limited, Wholly Owned Subsidiary (Transferor Company) into Jyothy Laboratories Limited (Transferee Company). The detailed disclosure is enclosed.Standalone & Consolidated Financial Results, Form A, Auditors Report, Immediate Release for March 31, 2016
Jyothy Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Form A for the period ended March 31, 20164. Consolidated Form A for the period ended March 31, 20165. Consolidated Auditors Report for the period ended March 31, 20166. Immediate Release for the period ended March 31, 2016Board recommends Final Dividend
Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2016, inter alia, have:1. Recommended Final Dividend of Re. 1/- (Rupee One Only) per equity share of Re. 1/- each for the financial year ended March 31, 2016, which if approved by the shareholders at the ensuing Annual General Meeting, will be paid/ dispatched on or before July 31, 2016;...